rs238132

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003244.4(TGIF1):​c.-33C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 1,554,452 control chromosomes in the GnomAD database, including 26,344 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 8088 hom., cov: 32)
Exomes 𝑓: 0.14 ( 18256 hom. )

Consequence

TGIF1
NM_003244.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.311

Publications

12 publications found
Variant links:
Genes affected
TGIF1 (HGNC:11776): (TGFB induced factor homeobox 1) The protein encoded by this gene is a member of the three-amino acid loop extension (TALE) superclass of atypical homeodomains. TALE homeobox proteins are highly conserved transcription regulators. This particular homeodomain binds to a previously characterized retinoid X receptor responsive element from the cellular retinol-binding protein II promoter. In addition to its role in inhibiting 9-cis-retinoic acid-dependent RXR alpha transcription activation of the retinoic acid responsive element, the protein is an active transcriptional co-repressor of SMAD2 and may participate in the transmission of nuclear signals during development and in the adult. Mutations in this gene are associated with holoprosencephaly type 4, which is a structural anomaly of the brain. Alternative splicing has been observed at this locus and multiple splice variants encoding distinct isoforms are described. [provided by RefSeq, Jul 2013]
TGIF1 Gene-Disease associations (from GenCC):
  • holoprosencephaly 4
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 18-3450457-C-A is Benign according to our data. Variant chr18-3450457-C-A is described in ClinVar as Benign. ClinVar VariationId is 259013.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.57 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGIF1NM_003244.4 linkc.-33C>A 5_prime_UTR_variant Exon 1 of 3 ENST00000343820.10 NP_003235.1 Q15583-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGIF1ENST00000343820.10 linkc.-33C>A 5_prime_UTR_variant Exon 1 of 3 1 NM_003244.4 ENSP00000339631.6 Q15583-2

Frequencies

GnomAD3 genomes
AF:
0.261
AC:
39592
AN:
151956
Hom.:
8063
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.576
Gnomad AMI
AF:
0.125
Gnomad AMR
AF:
0.149
Gnomad ASJ
AF:
0.141
Gnomad EAS
AF:
0.153
Gnomad SAS
AF:
0.170
Gnomad FIN
AF:
0.158
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.234
GnomAD2 exomes
AF:
0.160
AC:
25422
AN:
158684
AF XY:
0.156
show subpopulations
Gnomad AFR exome
AF:
0.581
Gnomad AMR exome
AF:
0.0964
Gnomad ASJ exome
AF:
0.152
Gnomad EAS exome
AF:
0.138
Gnomad FIN exome
AF:
0.164
Gnomad NFE exome
AF:
0.131
Gnomad OTH exome
AF:
0.160
GnomAD4 exome
AF:
0.143
AC:
200669
AN:
1402378
Hom.:
18256
Cov.:
33
AF XY:
0.143
AC XY:
98621
AN XY:
692056
show subpopulations
African (AFR)
AF:
0.592
AC:
18756
AN:
31662
American (AMR)
AF:
0.108
AC:
3891
AN:
36094
Ashkenazi Jewish (ASJ)
AF:
0.151
AC:
3814
AN:
25198
East Asian (EAS)
AF:
0.144
AC:
5188
AN:
35910
South Asian (SAS)
AF:
0.168
AC:
13361
AN:
79394
European-Finnish (FIN)
AF:
0.162
AC:
7961
AN:
49274
Middle Eastern (MID)
AF:
0.197
AC:
1122
AN:
5698
European-Non Finnish (NFE)
AF:
0.127
AC:
136891
AN:
1080988
Other (OTH)
AF:
0.167
AC:
9685
AN:
58160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
9901
19802
29702
39603
49504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5164
10328
15492
20656
25820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.261
AC:
39670
AN:
152074
Hom.:
8088
Cov.:
32
AF XY:
0.259
AC XY:
19285
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.576
AC:
23878
AN:
41442
American (AMR)
AF:
0.149
AC:
2275
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
491
AN:
3472
East Asian (EAS)
AF:
0.153
AC:
789
AN:
5142
South Asian (SAS)
AF:
0.172
AC:
828
AN:
4826
European-Finnish (FIN)
AF:
0.158
AC:
1673
AN:
10588
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.133
AC:
9061
AN:
67990
Other (OTH)
AF:
0.234
AC:
495
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1198
2396
3595
4793
5991
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
372
Bravo
AF:
0.270
Asia WGS
AF:
0.190
AC:
661
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly sequence Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.1
DANN
Benign
0.56
PhyloP100
-0.31
PromoterAI
0.035
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.6
Mutation Taster
=298/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs238132; hg19: chr18-3450455; COSMIC: COSV57910050; COSMIC: COSV57910050; API